First Header Logo Second Header Logo

Connection

James Mooney to Botulinum Toxins

This is a "connection" page, showing publications James Mooney has written about Botulinum Toxins.
Connection Strength

0.307
  1. Balkrishnan R, Camacho FT, Smith BP, Shilt JS, Jacks LK, Koman LA, Rascati KL, Mooney JF. Cost impact of botulinum toxin use in Medicaid-enrolled children with cerebral palsy. J South Orthop Assoc. 2002; 11(2):71-9.
    View in: PubMed
    Score: 0.196
  2. Mooney JF, Koman LA, Smith BP. Pharmacologic management of spasticity in cerebral palsy. J Pediatr Orthop. 2003 Sep-Oct; 23(5):679-86.
    View in: PubMed
    Score: 0.055
  3. Koman LA, Mooney JF, Smith BP, Goodman A, Mulvaney T. Management of spasticity in cerebral palsy with botulinum-A toxin: report of a preliminary, randomized, double-blind trial. J Pediatr Orthop. 1994 May-Jun; 14(3):299-303.
    View in: PubMed
    Score: 0.029
  4. Koman LA, Mooney JF, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop. 1993 Jul-Aug; 13(4):489-95.
    View in: PubMed
    Score: 0.027
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.